These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 8389658)

  • 1. Chromosome number and carmustine sensitivity in human gliomas.
    Shapiro JR; Pu PY; Mohamed AN; Galicich JH; Ebrahim SA; Shapiro WR
    Cancer; 1993 Jun; 71(12):4007-21. PubMed ID: 8389658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCNU-sensitivity in parental cells and clones from four freshly resected near-diploid human gliomas: an astrocytoma, an anaplastic astrocytoma and two glioblastomas multiforme.
    Shapiro JR; Ebrahim SA; Mohamed AN; Pu PY; Shapiro WR
    J Neurooncol; 1993 Mar; 15(3):209-27. PubMed ID: 8395568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective intra-arterial chemotherapy with BCNU in recurrent malignant gliomas.
    Bradac GB; Soffietti R; Riva A; Stura G; Sales S; Schiffer D
    Neuroradiology; 1992; 34(1):73-6. PubMed ID: 1313161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA content and chromosomal composition of malignant human gliomas.
    Bigner SH; Bjerkvig R; Laerum OD
    Neurol Clin; 1985 Nov; 3(4):769-84. PubMed ID: 3001489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of genomic abnormalities in human gliomas.
    Bello MJ; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Cancer Genet Cytogenet; 1994 Apr; 73(2):122-9. PubMed ID: 8174086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-representation of specific regions of chromosome 22 in cells from human glioma correlate with resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Hank NC; Shapiro JR; Scheck AC
    BMC Cancer; 2006 Jan; 6():2. PubMed ID: 16393339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF; Miller DC; Koslow M; Newcomb EW
    J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable response to 1,3-bis(2-chloroethyl)-1-nitrosourea of human glioma cells sorted according to DNA content.
    Kobayashi S; Hoshino T; Dougherty DV; Rosenblum ML
    J Neurooncol; 1984; 2(1):5-11. PubMed ID: 6088724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro analysis of BCNU-sensitivity in human malignant gliomas. II. Cross-resistance studies with cisplatinum and nitrosoureas.
    Gerosa MA; Rosenblum ML; Stevanoni G; Licata C; Della Corte V; Marcon C; Bricolo A; Tridente G
    Acta Neurol Scand; 1986 Jan; 73(1):66-70. PubMed ID: 3006422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCNU-DBD (Dibromodulcitol) chemotherapy of recurrent supratentorial anaplastic astrocytomas and glioblastomas.
    Vitanovics D; Sipos L; Afra D
    Neoplasma; 2002; 49(5):342-5. PubMed ID: 12458335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic alterations in low-grade, anaplastic astrocytomas and glioblastomas.
    Arslantas A; Artan S; Oner U; Müslümanoglu MH; Ozdemir M; Durmaz R; Arslantas D; Vural M; Cosan E; Atasoy MA
    Pathol Oncol Res; 2007; 13(1):39-46. PubMed ID: 17387387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of constitutional heterozygosity in human astrocytomas.
    Van de Kelft E; De Boulle K; Willems P; Martin JJ; Selosse P; Van der Auwera B
    Acta Neurochir (Wien); 1992; 117(3-4):172-7. PubMed ID: 1357919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors.
    Arnoldus EP; Wolters LB; Voormolen JH; van Duinen SG; Raap AK; van der Ploeg M; Peters AC
    J Neurosurg; 1992 Jun; 76(6):997-1003. PubMed ID: 1588436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro analysis of BCNU-sensitivity in human malignant gliomas. I. A model study with alkylating, cross-linking and carbamoylating agents in anaplastic astrocytomas of pediatric age.
    Gerosa MA; Rosenblum ML; Stevanoni G; Tommasi M; Della Corte V; Licata C; Bricolo A; Tridente G
    Acta Neurol Scand; 1985 Oct; 72(4):414-8. PubMed ID: 3002083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of chromosomal changes in human glioma progression. A cytogenetic study of 50 cases.
    Debiec-Rychter M; Alwasiak J; Liberski PP; Nedoszytko B; Babińska M; Mrózek K; Imieliński B; Borowska-Lehman J; Limon J
    Cancer Genet Cytogenet; 1995 Nov; 85(1):61-7. PubMed ID: 8536240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCNU-resistant human glioma cells with over-representation of chromosomes 7 and 22 demonstrate increased copy number and expression of platelet-derived growth factor genes.
    Scheck AC; Mehta BM; Beikman MK; Shapiro JR
    Genes Chromosomes Cancer; 1993 Nov; 8(3):137-48. PubMed ID: 7509621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of EGFR and PTEN numerical aberrations in the evaluation of diffusely infiltrating astrocytomas. Laboratory investigation.
    Mott RT; Turner KC; Bigner DD; McLendon RE
    J Neurosurg; 2008 Feb; 108(2):330-5. PubMed ID: 18240930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Karyotypes in 90 human gliomas.
    Thiel G; Losanowa T; Kintzel D; Nisch G; Martin H; Vorpahl K; Witkowski R
    Cancer Genet Cytogenet; 1992 Feb; 58(2):109-20. PubMed ID: 1551072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal analysis of gliomas.
    Kattar MM; Kupsky WJ; Shimoyama RK; Vo TD; Olson MW; Bargar GR; Sarkar FH
    Hum Pathol; 1997 Oct; 28(10):1166-79. PubMed ID: 9343324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal patterns in human malignant astrocytomas.
    Rey JA; Bello MJ; de Campos JM; Kusak ME; Ramos C; Benitez J
    Cancer Genet Cytogenet; 1987 Dec; 29(2):201-21. PubMed ID: 2824025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.